Literature DB >> 28856667

Respiratory syncytial virus infection influences tight junction integrity.

J I Kast1,2, A J McFarlane3, A Głobińska1,2,4, M Sokolowska1,2, P Wawrzyniak1,2, M Sanak5, J Schwarze3,6, C A Akdis1,2, K Wanke1,2.   

Abstract

Respiratory syncytial virus (RSV) is an important risk factor of asthma development and is responsible for severe respiratory tract infections. However, the influence of RSV infection on barrier function of bronchial epithelial cells in vitro and in vivo is still unclear. The aim of this study was to analyse the role of RSV in tight junction (TJ) regulation and to compare epithelial integrity between asthmatic and healthy individuals upon RSV infection. Healthy and asthmatic human bronchial epithelial cells (HBECs) were differentiated at air-liquid interface (ALI) and infected with RSV and ultraviolet (UV)-irradiated RSV. TJ expression and their integrity were analysed by quantitative polymerase chain reaction (qPCR), transepithelial resistance (TER) and paracellular flux. To determine the effect in vivo, BALB/c mice were infected intranasally with RSV or UV-irradiated RSV A2. Bronchoalveolar lavage and TJ integrity were analysed on days 1, 2, 4 and 6 post-infection by qPCR, bioplex and confocal microscopy. RSV increased barrier integrity in ALI cultures of HBEC from healthy subjects, but no effect was found in HBECs from asthmatics. This was not associated with an increase in TJ mRNA expression. In vivo, RSV induced lung inflammation in mice and down-regulated claudin-1 and occludin mRNA expression in whole lungs. Surprisingly, RSV infection was not observed in bronchial epithelial cells, but was found in the lung parenchyma. Decreased expression of occludin upon RSV infection was visible in mouse bronchial epithelial cells in confocal microscopy. However, there was no regulation of claudin-1 and claudin-7 at protein level.
© 2017 British Society for Immunology.

Entities:  

Keywords:  airway epithelial cells; asthma; respiratory syncytial virus; tight junctions

Mesh:

Substances:

Year:  2017        PMID: 28856667      PMCID: PMC5680068          DOI: 10.1111/cei.13042

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  42 in total

1.  [Real time quantitative PCR].

Authors:  D W Kim
Journal:  Exp Mol Med       Date:  2001-04-21       Impact factor: 8.718

Review 2.  Epithelium dysfunction in asthma.

Authors:  Stephen T Holgate
Journal:  J Allergy Clin Immunol       Date:  2007-12       Impact factor: 10.793

3.  Defective epithelial barrier function in asthma.

Authors:  Chang Xiao; Sarah M Puddicombe; Sarah Field; Joel Haywood; Victoria Broughton-Head; Ilaria Puxeddu; Hans Michael Haitchi; Elizabeth Vernon-Wilson; David Sammut; Nicole Bedke; Catherine Cremin; Jody Sones; Ratko Djukanović; Peter H Howarth; Jane E Collins; Stephen T Holgate; Phillip Monk; Donna E Davies
Journal:  J Allergy Clin Immunol       Date:  2011-07-12       Impact factor: 10.793

Review 4.  Respiratory syncytial virus infection and the tight junctions of nasal epithelial cells.

Authors:  Hiroyuki Tsutsumi; Takashi Kojima; Satoshi Hirakawa; Tomoyuki Masaki; Tamaki Okabayashi; Shinichi Yokota; Nobuhiro Fujii; Tetsuo Himi; Norimasa Sawada
Journal:  Adv Otorhinolaryngol       Date:  2011-08-18

Review 5.  Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation.

Authors:  Steve N Georas; Fariba Rezaee
Journal:  J Allergy Clin Immunol       Date:  2014-07-29       Impact factor: 10.793

6.  IL-10 and RANTES are elevated in nasopharyngeal secretions of children with respiratory syncytial virus infection.

Authors:  Hiroki Murai; Akihiko Terada; Mihoko Mizuno; Masami Asai; Yasutaka Hirabayashi; Seiki Shimizu; Takehiro Morishita; Hiroki Kakita; Mohamed Hamed Hussein; Tetsuya Ito; Ineko Kato; Kiyofumi Asai; Hajime Togari
Journal:  Allergol Int       Date:  2007-05-01       Impact factor: 5.836

7.  Claudin-18 deficiency is associated with airway epithelial barrier dysfunction and asthma.

Authors:  Kelly Sweerus; Marrah Lachowicz-Scroggins; Erin Gordon; Michael LaFemina; Xiaozhu Huang; Mihir Parikh; Cindy Kanegai; John V Fahy; James A Frank
Journal:  J Allergy Clin Immunol       Date:  2016-04-20       Impact factor: 10.793

8.  Rhinovirus-induced interferon production is not deficient in well controlled asthma.

Authors:  Annemarie Sykes; Jonathan Macintyre; Michael R Edwards; Ajerico Del Rosario; Jennifer Haas; Vera Gielen; Onn Min Kon; Mark McHale; Sebastian L Johnston
Journal:  Thorax       Date:  2013-10-14       Impact factor: 9.139

9.  Increased nuclear suppressor of cytokine signaling 1 in asthmatic bronchial epithelium suppresses rhinovirus induction of innate interferons.

Authors:  Vera Gielen; Annemarie Sykes; Jie Zhu; Brian Chan; Jonathan Macintyre; Nicolas Regamey; Elisabeth Kieninger; Atul Gupta; Amelia Shoemark; Cara Bossley; Jane Davies; Sejal Saglani; Patrick Walker; Sandra E Nicholson; Alexander H Dalpke; Onn-Min Kon; Andrew Bush; Sebastian L Johnston; Michael R Edwards
Journal:  J Allergy Clin Immunol       Date:  2015-01-25       Impact factor: 10.793

10.  Rhinoviruses significantly affect day-to-day respiratory symptoms of children with asthma.

Authors:  Euan R Tovey; Sacha Stelzer-Braid; Brett G Toelle; Brian G Oliver; Helen K Reddel; Christiana M Willenborg; Yvonne Belessis; Frances L Garden; Adam Jaffe; Roxanne Strachan; Darryl Eyles; William D Rawlinson; Guy B Marks
Journal:  J Allergy Clin Immunol       Date:  2014-12-02       Impact factor: 10.793

View more
  25 in total

Review 1.  Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases.

Authors:  Ioana Agache; Cezmi A Akdis
Journal:  J Clin Invest       Date:  2019-03-11       Impact factor: 14.808

Review 2.  Tight Junctions, the Epithelial Barrier, and Toll-like Receptor-4 During Lung Injury.

Authors:  Nachiket M Godbole; Asif Alam Chowdhury; Neha Chataut; Shanjana Awasthi
Journal:  Inflammation       Date:  2022-07-02       Impact factor: 4.657

Review 3.  Nutrients Interaction with the Immune System.

Authors:  S Noor; S Piscopo; A Gasmi
Journal:  Arch Razi Inst       Date:  2021-12-30

4.  Disruption of the airway epithelial barrier in a murine model of respiratory syncytial virus infection.

Authors:  Carrie C Smallcombe; Debra T Linfield; Terri J Harford; Vladimir Bokun; Andrei I Ivanov; Giovanni Piedimonte; Fariba Rezaee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-11-29       Impact factor: 5.464

5.  Porcine Reproductive and Respiratory Syndrome Virus Structural Protein GP3 Regulates Claudin 4 To Facilitate the Early Stages of Infection.

Authors:  Guofei Ding; Jiaqi Liu; Qingyuan Shao; Bin Wang; Jian Feng; Yingchao Li; Li Li; Shengliang Cao; Fangyuan Cong; Yuzhong Zhao; Sidang Liu; Yihong Xiao
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

Review 6.  Potential Role of Vitamins and Zinc on Acute Respiratory Infections Including Covid-19.

Authors:  Indah K Murni; Endy P Prawirohartono; Rina Triasih
Journal:  Glob Pediatr Health       Date:  2021-05-31

Review 7.  Virus-associated disruption of mucosal epithelial tight junctions and its role in viral transmission and spread.

Authors:  Sharof Tugizov
Journal:  Tissue Barriers       Date:  2021-07-09

Review 8.  Surviving Deadly Lung Infections: Innate Host Tolerance Mechanisms in the Pulmonary System.

Authors:  Meredith J Crane; Kayla M Lee; Ethan S FitzGerald; Amanda M Jamieson
Journal:  Front Immunol       Date:  2018-06-22       Impact factor: 7.561

Review 9.  Acute Respiratory Barrier Disruption by Ozone Exposure in Mice.

Authors:  Milena Sokolowska; Valerie F J Quesniaux; Cezmi A Akdis; Kian Fan Chung; Bernhard Ryffel; Dieudonnée Togbe
Journal:  Front Immunol       Date:  2019-09-13       Impact factor: 7.561

10.  Determining Immune and miRNA Biomarkers Related to Respiratory Syncytial Virus (RSV) Vaccine Types.

Authors:  Lydia J Atherton; Patricia A Jorquera; Abhijeet A Bakre; Ralph A Tripp
Journal:  Front Immunol       Date:  2019-10-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.